NTRK2 and Alzheimer disease: This paper presents a review of stem cell therapies for AD focusing on its action on the BDNF/TrkB signalling pathway and its downstream cascades, particularly the PI3K/Akt, MAPK/ERK and PLC-γ signalling pathways.